F. T. Costa

发表

Yeast-based high-throughput screens for discovery of kinase inhibitors for neglected diseases.

E. Bilsland, P. Sunnerhagen, G. C. Cassiano, 2021, Advances in protein chemistry and structural biology.

Computational and Experimental Approaches Identify Beta-Blockers as Potential SARS-CoV-2 Spike Inhibitors

S. Ekins, C. Andrade, K. Pearce, 2022, ACS omega.

Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential Mechanisms

Carolina Q. Sacramento, S. Ekins, R. Baric, 2020, bioRxiv.

Crotofolane Diterpenoids and Other Constituents Isolated from Croton kilwae

K. Rissanen, P. Sunnerhagen, T. Bergström, 2023, Journal of natural products.

Machine Learning Models Identify Inhibitors of SARS-CoV-2

Thomas Rogers, Sean Ekins, Kimberley M. Zorn, 2020, bioRxiv.

Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax

E. Bilsland, C. Andrade, P. Sunnerhagen, 2020, Antimicrobial Agents and Chemotherapy.

Chemogenomics and bioinformatics approaches for prioritizing kinases as drug targets for neglected tropical diseases.

Nicholas Furnham, Carolina Horta Andrade, Joyce Villa Verde Bastos Borba, 2020, Advances in protein chemistry and structural biology.

Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons

S. Oliver, J. Ajioka, D. Spring, 2018, BMC Biotechnology.

Update and elucidation of Plasmodium kinomes: Prioritization of kinases as potential drug targets for malaria

Joyce V. B. Borba, C. Andrade, Arthur C. Silva, 2022, Computational and structural biotechnology journal.

Targeting malaria protein kinases.

C. Andrade, D. A. Rodrigues, G. C. Cassiano, 2020, Advances in protein chemistry and structural biology.

Therapeutic effect of Lipoxin A4 in malaria‐induced acute lung injury

P. Rocco, M. Henriques, J. L. Silva-Filho, 2018, Journal of leukocyte biology.

Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii.

C. Rapôso, Alejandro J. Paredes, L. T. Ferreira, 2021, Journal of controlled release : official journal of the Controlled Release Society.

A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants

D. Fidock, John Okombo, G. C. Cassiano, 2024, PLoS pathogens.